We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures to a variety of diseases. By attacking the disease directly with our novel nanoparticle-based technologies and working strategically with our medical and scientific partners we seek to provide treatments and cures previously unavailable to doctors and their patients.
$105M sweet spot round size
2015
$105M
from 3 investors over 1 rounds
Cour Pharmaceuticals Development Co., Inc. raised $105M on March 1, 2024
Investors: Alpha Wave Ventures, Lumira Ventures and + 5 Other investors